Holen Sie sich die Stockscreener-App
22.09
3.66%
0.78
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TEVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Teva Pharmaceutical Industries Ltd Adr Aktie (TEVA) Neueste Nachrichten
My Top 10 Portfolio Holdings for 2025 - The Motley Fool
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 90-Plus RS Rating - Inkl
Sandoz Group AG Sponsored ADR (SDZNY) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Wall Street Analysts Think Molecular Partners AG Sponsored ADR (MOLN) Could Surge 80.72%: Read This Before Placing a Bet - Yahoo Finance
Is Kingsoft Cloud (KC) Outperforming Other Computer and Technology Stocks This Year? - Yahoo Finance
Opera Gains 27% in 3 Months: Should You Buy, Sell or Hold the Stock? - Yahoo Finance
Upcoming Nasdaq-100 changes could boost the stocks of these 11 companies - Yahoo Finance
Teva Pharmaceutical ADR Clears Technical Benchmark, Hitting 80-Plus RS Rating - Investor's Business Daily
Hello Group Inc. Sponsored ADR (MOMO) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance
Are Medical Stocks Lagging Adagene (ADAG) This Year? - Yahoo Finance
Teva Pharmaceutical ADR Gets Relative Strength Rating Upgrade - Inkl
Saudi Arabia Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Why Sony Group Corporation (SONY) Is One of the Best ADR Stocks to Invest in? - Yahoo Finance
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? - Yahoo Finance
New Strong Buy Stocks for November 26th - Yahoo Finance
Why MINISO Group Holding Limited Unsponsored ADR (MNSO) Outpaced the Stock Market Today - Yahoo Finance
Petrobras to Distribute R$ 20 Billion in Dividends - Yahoo Finance
10 Stocks With the Largest Fair Value Estimate Increases After Q3 Earnings - Morningstar
Is Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Full Truck Alliance Co. Ltd. Sponsored ADR (YMM) Q3 Earnings and Revenues Beat Estimates - Yahoo Finance
UK Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
XPeng Inc. Sponsored ADR (XPEV) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Sea Limited Q3 Earnings Miss Estimates, Shares Rise on Revenue Growth - Yahoo Finance
Such Is The Power Of CNH Industrial NV (NYSE: CNH) - Stocks Register
Hannover Rueck SE Reports Strong 2024 Earnings Growth - Yahoo Finance
11 New 4-Star Stocks - Morningstar
'This Is A New Teva,' Says CEO. But Investors Don't Seem To Believe. - Investor's Business Daily
XPeng Inc. Sponsored ADR (XPEV) Stock Moves -1.06%: What You Should Know - Yahoo Finance
Where Do Analysts See Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Heading? - Stocks Register
Biliary Tract Cancer Market Research Report 2024-2030 with Analyst Recommendations - GlobeNewswire Inc.
Sea Limited Sponsored ADR (SE) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
South Africa Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is Alstom (ALSMY) Outperforming Other Transportation Stocks This Year? - Yahoo Finance
Spain Head And Neck Cancer Therapeutics Market Size & Outlook, 2030 - Grand View Research
Italy Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Germany Central Nervous System Therapeutic Market Size & Outlook, 2028 - Grand View Research
Is EXL Service (EXLS) Stock Outpacing Its Business Services Peers This Year? - Yahoo Finance
Is DMARKET Electronic Services & Trading (HEPS) Outperforming Other Retail-Wholesale Stocks This Year? - Yahoo Finance
Is AllianceBernstein (AB) Stock Outpacing Its Finance Peers This Year? - Yahoo Finance
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 5.28 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: The Story of a 52-Week Stock Range - The InvestChronicle
Ophthalmic Disease Therapeutics Market Analysis by Age-related Macular Degeneration, Diabetic Macular Edema, & Other Retinal Disorders - GlobeNewswire Inc.
Is American Outdoor Brands (AOUT) Outperforming Other Consumer Discretionary Stocks This Year? - Yahoo Finance
Weekly Upgrades and Downgrades - InvestorPlace
Monitoring Teva- Pharmaceutical Industries Ltd. ADR (TEVA) after recent insider movements - Knox Daily
Li Auto Inc. Sponsored ADR (LI) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
Views of Wall Street’s Leading Experts on Teva- Pharmaceutical Industries Ltd. ADR - SETE News
Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Exec. VP, European Commercial Daniell Richard sells 98,943 shares of the company – Knox Daily - Knox Daily
Qifu Technology Inc. ADR (QFIN) gets rating Initiated from Nomura - Knox Daily
Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Is Currently 1.45 below its 200 Period Moving Avg: What Does This Mean? – The DBT News - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Keeping an Eye on Teva- Pharmaceutical Industries Ltd. ADR (TEVA) After Insider Trading Activity - Knox Daily
TEVA’s current quarter earnings: What analysts forecast? - US Post News
Taking a look at what insiders are doing to gauge the Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s direction - Knox Daily
HP Stock Sees Surge of Approximately 3.50% in Last Five Days - Knox Daily
RPM International, Inc. [RPM] Shares Rise 6.30 % on Wednesday - Knox Daily
Atour Lifestyle Holdings Limited Sponsored ADR (ATAT) Moves 6.2% Higher: Will This Strength Last? - Yahoo Finance
Alight Inc. (ALIT) gets rating Downgrade from JP Morgan - Knox Daily
Sea Limited Sponsored ADR (SE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
TEVA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Keycorp (NYSE: KEY) Up 50.91% This Year: What Is Going To Happen Next - Stocks Register
3.22%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):